Skip to main content
. 2012 Oct 19;24(1):301–310. doi: 10.1007/s00198-012-2175-7

Fig. 3.

Fig. 3

Mean percent change from baseline ± SE in bone turnover markers over 2 years in women receiving risedronate 5 mg IR daily (solid lines with black circles), 35 mg DR FB weekly (dashed lines with black squares), or 35 mg DR BB weekly (circle dashed lines with black triangles). Asterisk represents statistically significant difference between IR daily and DR weekly treatment group